Phase III, Placebo-Controlled Trial of Three Doses of Citalopram for the Treatment of Hot Flashes: NCCTG Trial N05C9

PURPOSE: Up to 75% of women experience hot flashes, which can negatively impact quality of life. As hot flash physiology is not definitively understood, it cannot be assumed that effective agents represent class effects. Therefore, there is a continued need for rigorous evaluation to identify effect...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Barton, Debra L., LaVasseur, Beth I., Sloan, Jeff A., Stawis, Allen N., Flynn, Kathleen A., Dyar, Missy, Johnson, David B., Atherton, Pamela J., Diekmann, Brent, Loprinzi, Charles L.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Clinical Oncology 2010
Pynciau:
Original Reports
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2903326/
https://ncbi.nlm.nih.gov/pubmed/20498389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.26.6379
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg